Monographie - Pentamidine isetionate - Stabilis 4.0

Viimeisin päivitys :
08/05/2024

Antibiootit

Pentamidine isetionate

Injektioneste

Stabilius liuoksessa

Stabilius seoksissa

Tekijät, jotka vaikuttavat stabiliuteen

Yhteensopivuus

Antotapa

Viitteet

Pdf

Kemiallinen rakenne

Kauppanimi

Kauppanimi

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

DBL Pentamidine isetionate	Malesia
Manicare	Argentiina
Nebupent	Yhdysvallat
Pentacarinat	Belgia, Espanja, Hollanti, Iso-Britannia, Italia, Itävalta, Kolumbia, Kreikka, Luxemburg, New Zealand, Ranska, Ruotsi, Saksa, Suomi, Sveitsi, Tanska
Pentam	Yhdysvallat
Pentamidina	Argentiina, Espanja
Pentamidine isethionate	Australia, Kanada, Malesia, Yhdysvallat
Pentamina	Portugali

Viitteet

Injektioneste

Viitteet : Pentamidine isetionate

	Tyyppi	Julkaisu
36	Lehti	Alex S, Gupta SL, Minor JR, Turcovski-Corrales S, Gallelli JF, Taub D, Piscitelli SC. Compatibility and activity of aldesleukin (recombinant interleukin-2) in presence of selected drugs during simulated Y-site administration: Evaluation of three methods. Am J Health-Syst Pharm 1995 ; 52: 2423-2426.
73	Lehti	Lor E, Takagi J. Visual compatibility of foscarnet with other injectable drugs. Am J Hosp Pharm 1990 ; 47: 157-159.
198	Lehti	Gayed AA, Kheshary PR, Hinkle RL. Visual compatibility of diltiazem injection with various diluents and medications during simulated Y-site injection. Am J Health-Syst Pharm 1995 ; 52: 516-520.
275	Lehti	Lewis JD, El-Gendy A. Cephalosporin-pentamidine isethionate incompatibilities. Am J Health-Syst Pharm 1996 ; 53: 1461-1462.
337	Lehti	Bashaw ED, Amantea MA, Minor JR, Galleli JF. Visual compatibility of zidovudine with other drugs during simulated Y-site administration. Am J Hosp Pharm 1988 ; 45: 2532-2533.
424	Lehti	De NC, Alam AS, Kapoor JN. Stability of pentamidine isethionate in 5% dextrose and 0.9% sodium chloride injections. Am J Hosp Pharm 1986 ; 43: 1486-1488.
496	Lehti	Lor E, Sheybani T, Takagi J. Visual compatibility of fluconazole with commonly used injectable drugs during simulated Y-site administration. Am J Hosp Pharm 1991 ; 48: 744-746.
604	Laboratorio	Stabilité des médicaments dans l'Intermate® SV50, 100, 200 Baxter 1998
1135	Lehti	Baltz JK, Kennedy P, Minor JR, Gallelli J. Visual compatibility of foscarnet with other injectable drugs during simulated Y-site administration. Am J Hosp Pharm 1990 ; 47: 2075-2077.
1235	Lehti	Leigh PH, Buddle GC. Pentamidine infusion stability. Br J Pharm Pract 1988 ; 10: 22-23.
1625	Lehti	Trissel LA, Saenz C, Williams YW, Ingram D. Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration. Int J Pharm Compound 2001 ; 5: 314-321.
1925	Lehti	Trissel LA , Williams KY, Gilbert DL. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions. J Am Pharm Assoc 2000 ; 40: 515-519.
3543	Laboratorio	Ceftazidime – Summary of Product Characteristics Wockhardt 2013
3559	Laboratorio	Pentamidine diiséthionate (Pentacarinat®) - Résumé des caractéristiques du produit Sanofi Aventis France 2013
3560	Laboratorio	Linezolid (Zyvox®) - Summary of Product Characteristics Pharmacia 2013
3662	Laboratorio	Foscavir (Foscarnet®) - Summary of Product Characteristics Clinigen 2014

Mentions Légales